CSF2 and pulmonary alveolar proteinosis: Consistent with the protective effect of GM-CSF, GM-CSF-deficient mice exhibit pulmonary alveolar proteinosis (PAP) (79), which ultimately led to therapies including inhaled GM-CSF to treat this disease (80).